which glp 1 drugs are approved for obesity Indications GLP-1/GIP RA Summary Sheet and Beyond! GLP-1 drug coverage for obesity
Description
The result is a market with enormous demand, high willingness to pay, and longstanding dissatisfaction
For offices and small businesses, its also a simple way to invest in employee well-being with something everyone can appreciate
One large study found that semaglutide use was associated with improved joint outcomes, raising the possibility of a disease-modifying effect
(PubMed) Huber H et al
Clin Res Cardiol
55:835-847 [PubMed: 20110146] 87
